Prospective Cohort for Adult Hemophagocytosis

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Hemophagocytic Lymphohistiocytoses

Interventions

DRUG

Steroids

High dose dexamethasone 20 mg PO or IV

DRUG

Etoposide

Etoposide 150mg/BSA

Trial Locations (1)

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER